NBY - NovaBay Pharmaceuticals, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
2.15
+0.02 (+0.85%)
As of 1:20PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close2.13
Open2.15
Bid0.00 x 3000
Ask0.00 x 1800
Day's Range2.11 - 2.15
52 Week Range2.00 - 4.80
Volume2,589
Avg. Volume11,381
Market Cap36.742M
Beta-0.67
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Benzinga5 months ago

    NovaBay Pharmaceuticals Q4 Earnings Outlook

    On Tuesday, NovaBay Pharmaceuticals (NYSE: NBY ) will release its latest earnings report. Decipher the announcement with Benzinga's help. Earnings and Revenue NovaBay Pharmaceuticals EPS will likely be ...

  • Reuters5 months ago

    BRIEF-Jinzi Ham's Unit Scraps Plan To Invest In Novabay Pharma, To Boost Asset Management Subsidiary's Capital

    (Correct second bullet to boost unit’s capital by 90 mln yuan, instead of 90-100 mln yuan) March 1 (Reuters) - Jinzi Ham Co Ltd : * SAYS UNIT SCRAPS PLAN TO INVEST IN NOVABAY PHARMACEUTICALS INC * SAYS ...

  • Capital Cube8 months ago

    ETFs with exposure to NovaBay Pharmaceuticals, Inc. : December 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to NovaBay Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to NBY-US. Comparing the performance and risk of NovaBay Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
    Capital Cube8 months ago

    NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017

    Categories: Yahoo FinanceGet free summary analysis NovaBay Pharmaceuticals, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of NovaBay Pharmaceuticals, Inc. – Johnson & Johnson, Tetraphase Pharmaceuticals, Inc., NanoViricides, Inc. and Sonoma Pharmaceuticals, Inc. (JNJ-US, TTPH-US, NNVC-US and SNOA-US) that have also reported for this period. ... Read more (Read more...)

  • Reuters9 months ago

    BRIEF-Jinzi Ham's unit to invest in Novabay Pharma and become its biggest shareholder

    Nov 14 (Reuters) - Jinzi Ham Co Ltd * Says unit signs agreement to buy shares in U.S. Novabay Pharmaceuticals Inc for a combined $27.06 million * Says unit will hold 37.14 percent stake in Novabay Pharmaceuticals ...

  • Capital Cube11 months ago

    ETFs with exposure to NovaBay Pharmaceuticals, Inc. : September 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to NovaBay Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to NBY-US. Comparing the performance and risk of NovaBay Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
    Capital Cube11 months ago

    NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017

    Categories: Yahoo FinanceGet free summary analysis NovaBay Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of NovaBay Pharmaceuticals, Inc. – Johnson & Johnson, Cempra, Inc., Oragenics, Inc., Tetraphase Pharmaceuticals, Inc. and Sonoma Pharmaceuticals, Inc. (JNJ-US, CEMP-US, OGEN-US, TTPH-US and SNOA-US) that have also reported ... Read more (Read more...)